Prevalence and Clinical Characteristics of Psoriasis in Spondyloarthritis: a Descriptive Analysis of 275 Patients
Overview
Authors
Affiliations
Objectives: To assess the prevalence of psoriasis among a cohort of patients with spondyloarthritis (SpA), to describe the clinical characteristics of psoriasis and associations with other manifestations.
Methods: This is a retrospective single-centre observational study. The patients were diagnosed with definite SpA (expert opinion), either axial or peripheral. Each patient underwent a direct interview by a physician. The data regarding history of psoriasis and its clinical characteristics were collected. Univariate and multivariate analyses of patients with versus without psoriasis were carried out.
Results: In all, 275 SpA patients were assessed: mean disease duration 16.7±11.8 years, 61.4% were men, 69.1% were diagnosed as axial SpA and 17.8% as peripheral SpA. In all, 84 patients (30.5%) had present or past psoriasis. The prevalence of psoriasis was high whatever the clinical presentation. Psoriasis was present before or concomitantly to diagnosis of SpA in 59/84 patients (70.2%). The most common types of psoriasis were plaque (66.7% of patients with psoriasis) and scalp psoriasis (65.5%). Other localisations were not rare, including palmoplantar pustulosis (20.2%) or nail psoriasis (19.1%). Patients with versus without psoriasis differed only through a lower proportion of radiological sacroiliitis (57.5% vs. 81.3 %, p<0.001).
Conclusions: With a prevalence of 30.5%, i.e. ten times higher than in the general population, this study confirms that psoriasis is a frequent and early manifestation in SpA and that a systematic search for psoriasis (e.g. scalp) is relevant in SpA for clinical practice, whatever the clinical presentation of SpA.
Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis.
Rondags A, van Marle L, Horvath B, Wink F, Arends S, Spoorenberg A Arthritis Res Ther. 2023; 25(1):145.
PMID: 37559146 PMC: 10410990. DOI: 10.1186/s13075-023-03119-2.
Dauchez A, Dougados M, Kemula M, Regnier E, Aractingi S, Molto A Rheumatol Int. 2022; 42(4):651-657.
PMID: 35152321 DOI: 10.1007/s00296-022-05099-z.
Skin manifestations in spondyloarthritis.
Meier K, Schloegl A, Poddubnyy D, Ghoreschi K Ther Adv Musculoskelet Dis. 2020; 12:1759720X20975915.
PMID: 33343725 PMC: 7727049. DOI: 10.1177/1759720X20975915.